Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 67296-2125

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 67296-2125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Meto-100mg-100s (Meto 100mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 100 mg strength. The label indicates 100 tablets in the package, with a barcode and storage instructions. Manufactured by Granules India Limited, made in India, and for Granules Pharmaceuticals Inc., Chantilly, VA. The label also includes dosage form and cautionary storage details.*

FDA Label Image

Meto-200mg-100s (Meto 200mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets, USP, showing a strength of 200 mg. The label includes storage instructions, a barcode, manufacturing details by Granules India Limited in India, and the product is manufactured for Granules Pharmaceuticals Inc. in Chantilly, VA. The package contains 100 tablets.*

FDA Label Image

Meto-25mg-100s (Meto 25mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets, USP 25 mg, showing 100 tablets. The label displays the product name, strength, dosage form, storage instructions, barcode, and manufacturing information. Manufactured by Granules India Limited in India for Granules Pharmaceuticals Inc., Chantilly, VA.*

FDA Label Image

Meto-50mg-100s (Meto 50mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength, available in a bottle of 100 tablets. The label states it contains 47.5 mg metoprolol succinate USP equivalent to 50 mg metoprolol tartrate. Manufactured by Granules India Limited and for Granules Pharmaceuticals Inc. Includes storage instructions, a barcode, and a designated area for batch coding with 2D barcode information.*

FDA Label Image

Meto-figure.jpg (Meto Figure)

A forest plot titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for multiple subgroups comparing metoprolol succinate extended-release tablets to placebo across three outcomes: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include geographic location, NYHA class, ejection fraction levels, ischemic etiology, sex, race, myocardial infarction history, diabetes status, hypertension history, and heart rate categories.*

FDA Label Image

Meto-structure.jpg (Meto Structure)

Chemical structure of metoprolol succinate, showing the molecular components and arrangement characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.